Douglas Donelan

Otsuka Phamaceuticals
Unbranded campaign to drive awareness and encourage testing for Autosomal Dominant Polycystic Kidney Disease (ADPKD), a hereditary, progressive disease that impacts the size and function of the kidneys. The objective was to create a disruptive, visually impactful and motivating campaign for at-risk audiences.

scPharmaceuticals
DTC campaign to drive awareness and adoption of FUROSCIX, the first FDA-approved, self-administered treatment of Furosimide for advanced heart failure patients. Pivotal to the communication was illustrating the urgent nature and dire circumstances of the affliction, and empower patients to take control.

MagnaCare
Social content for TPA managed healthcare company designed to drive acquisition among key labor union decision makers. The facebook campaign highlights MagnaCare’s range of offerings, speaking to their trusted experience – delivering affordable, high-quality solutions that benefit union members.

United States Classic Racing Association
Promotional campaign supporting the racing organization’s premier annual event.

CycleSmith Track Days
Complete rebranding and design for motorcycle track day organization.

Pfizer
HCP campaign promoting Cutaquig, the only FDA-approved, high concentration (16.5%) subcutaneous immunoglobulin infusion for patients with Primary Immunodeficiency. The challenge was to illustrate the "two sides" physicians consider when initiating treatment: providing protection, while ensuring tolerability.

Oncopeptides AB
Pitch concept to drive awareness of Pepaxti, a new weapon empowering HCPs in the fight against Relapsed or Refractory Multiple Myeloma. The critical communication objective was to inform physicians of the novel MOA, a first-in-class peptidase activated alkylator that appears "passive" as it enters into the tumor cell, then "explodes" to trigger cell death.